

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 9.91199137 |
| 2 | DNA deamination (GO:0045006) | 9.44516284 |
| 3 | negative T cell selection (GO:0043383) | 8.78104675 |
| 4 | negative thymic T cell selection (GO:0045060) | 8.70307019 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.65175171 |
| 6 | regulation of gamma-delta T cell differentiation (GO:0045586) | 7.52028979 |
| 7 | regulation of isotype switching to IgG isotypes (GO:0048302) | 7.46285885 |
| 8 | positive thymic T cell selection (GO:0045059) | 7.39672142 |
| 9 | thymic T cell selection (GO:0045061) | 7.12942864 |
| 10 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 7.01405345 |
| 11 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 6.87162750 |
| 12 | positive T cell selection (GO:0043368) | 6.80040478 |
| 13 | regulation of gamma-delta T cell activation (GO:0046643) | 6.76632332 |
| 14 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.75015004 |
| 15 | T cell migration (GO:0072678) | 6.70248600 |
| 16 | interferon-gamma production (GO:0032609) | 6.62470350 |
| 17 | leukocyte aggregation (GO:0070486) | 6.52600065 |
| 18 | T cell selection (GO:0045058) | 6.49073209 |
| 19 | sequestering of actin monomers (GO:0042989) | 6.30048404 |
| 20 | T cell receptor signaling pathway (GO:0050852) | 6.21000700 |
| 21 | actin nucleation (GO:0045010) | 6.18498254 |
| 22 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.83152181 |
| 23 | negative regulation of cell killing (GO:0031342) | 5.83152181 |
| 24 | regulation of T cell tolerance induction (GO:0002664) | 5.69264732 |
| 25 | response to interleukin-15 (GO:0070672) | 5.50672363 |
| 26 | cellular response to interleukin-15 (GO:0071350) | 5.45874512 |
| 27 | T cell costimulation (GO:0031295) | 5.45076428 |
| 28 | lymphocyte costimulation (GO:0031294) | 5.37418528 |
| 29 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.23780937 |
| 30 | regulation of alpha-beta T cell proliferation (GO:0046640) | 5.20563217 |
| 31 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.12454861 |
| 32 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.12454861 |
| 33 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 5.09234429 |
| 34 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 5.07589715 |
| 35 | regulation of T cell receptor signaling pathway (GO:0050856) | 5.00986350 |
| 36 | antigen receptor-mediated signaling pathway (GO:0050851) | 5.00606104 |
| 37 | negative regulation by host of viral transcription (GO:0043922) | 5.00090269 |
| 38 | cytolysis (GO:0019835) | 4.98612879 |
| 39 | negative regulation of viral genome replication (GO:0045071) | 4.87243878 |
| 40 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.84736560 |
| 41 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.73668651 |
| 42 | pyrimidine nucleoside catabolic process (GO:0046135) | 4.73328185 |
| 43 | positive regulation of interleukin-8 secretion (GO:2000484) | 4.73215792 |
| 44 | negative regulation of T cell apoptotic process (GO:0070233) | 4.70089675 |
| 45 | positive regulation of tolerance induction (GO:0002645) | 4.67949596 |
| 46 | lymphocyte chemotaxis (GO:0048247) | 4.61013790 |
| 47 | mast cell activation (GO:0045576) | 4.57280142 |
| 48 | regulation of isotype switching (GO:0045191) | 4.56801048 |
| 49 | regulation of T cell chemotaxis (GO:0010819) | 4.51878275 |
| 50 | positive regulation of T cell chemotaxis (GO:0010820) | 4.51878275 |
| 51 | positive regulation of interleukin-2 production (GO:0032743) | 4.50532379 |
| 52 | regulation of B cell differentiation (GO:0045577) | 4.48139118 |
| 53 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.45769359 |
| 54 | positive regulation of isotype switching (GO:0045830) | 4.45340875 |
| 55 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.37783124 |
| 56 | activated T cell proliferation (GO:0050798) | 4.34968805 |
| 57 | negative regulation of type 2 immune response (GO:0002829) | 4.28614456 |
| 58 | positive regulation of B cell differentiation (GO:0045579) | 4.21319672 |
| 59 | homeostasis of number of cells within a tissue (GO:0048873) | 4.20585386 |
| 60 | regulation of lymphocyte chemotaxis (GO:1901623) | 4.20195310 |
| 61 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.18782072 |
| 62 | regulation of immunoglobulin production (GO:0002637) | 4.11794861 |
| 63 | tolerance induction (GO:0002507) | 4.07160648 |
| 64 | regulation of tolerance induction (GO:0002643) | 4.04869372 |
| 65 | regulation of immunoglobulin mediated immune response (GO:0002889) | 4.04420941 |
| 66 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 4.02371537 |
| 67 | mast cell activation involved in immune response (GO:0002279) | 4.01495532 |
| 68 | mast cell degranulation (GO:0043303) | 4.01495532 |
| 69 | regulation of regulatory T cell differentiation (GO:0045589) | 4.00256593 |
| 70 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.99559151 |
| 71 | positive regulation of B cell mediated immunity (GO:0002714) | 3.96439018 |
| 72 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.96439018 |
| 73 | barbed-end actin filament capping (GO:0051016) | 3.95142479 |
| 74 | gap junction assembly (GO:0016264) | 3.94011977 |
| 75 | negative regulation of stress fiber assembly (GO:0051497) | 3.93652655 |
| 76 | macrophage chemotaxis (GO:0048246) | 3.92000738 |
| 77 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.90729512 |
| 78 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.90729512 |
| 79 | regulation of defense response to virus by virus (GO:0050690) | 3.89848564 |
| 80 | regulation of B cell mediated immunity (GO:0002712) | 3.89297323 |
| 81 | leukocyte cell-cell adhesion (GO:0007159) | 3.88443317 |
| 82 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.87764376 |
| 83 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.82513097 |
| 84 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.82513097 |
| 85 | alpha-beta T cell differentiation (GO:0046632) | 3.78193631 |
| 86 | positive regulation of lymphocyte migration (GO:2000403) | 3.77792088 |
| 87 | regulation of response to interferon-gamma (GO:0060330) | 3.77079684 |
| 88 | positive regulation of humoral immune response (GO:0002922) | 3.76746696 |
| 89 | eosinophil chemotaxis (GO:0048245) | 3.76346505 |
| 90 | lymphocyte migration (GO:0072676) | 3.76132500 |
| 91 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.75303605 |
| 92 | positive regulation of DNA recombination (GO:0045911) | 3.73685810 |
| 93 | regulation of activation of Janus kinase activity (GO:0010533) | 3.72025775 |
| 94 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.70777508 |
| 95 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.70457740 |
| 96 | T cell differentiation (GO:0030217) | 3.67427628 |
| 97 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.65342246 |
| 98 | alpha-beta T cell activation (GO:0046631) | 3.65213464 |
| 99 | T cell activation (GO:0042110) | 3.64436108 |
| 100 | regulation of interleukin-8 secretion (GO:2000482) | 3.56378419 |
| 101 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.56267336 |
| 102 | positive regulation of immunoglobulin production (GO:0002639) | 3.55254377 |
| 103 | positive regulation of cell killing (GO:0031343) | 3.55141171 |
| 104 | cellular defense response (GO:0006968) | 3.48349984 |
| 105 | regulation of immunoglobulin secretion (GO:0051023) | 3.42872476 |
| 106 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.42781838 |
| 107 | T-helper cell differentiation (GO:0042093) | 3.42781838 |
| 108 | positive regulation of T cell migration (GO:2000406) | 3.41458087 |
| 109 | eosinophil migration (GO:0072677) | 3.41320415 |
| 110 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.40695550 |
| 111 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.40180202 |
| 112 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.40047525 |
| 113 | chemokine-mediated signaling pathway (GO:0070098) | 3.38083080 |
| 114 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.37536216 |
| 115 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.37195112 |
| 116 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.35664295 |
| 117 | regulation of viral genome replication (GO:0045069) | 3.35130917 |
| 118 | regulation of interleukin-2 production (GO:0032663) | 3.34273995 |
| 119 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.33984012 |
| 120 | NIK/NF-kappaB signaling (GO:0038061) | 3.29375183 |
| 121 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.28944902 |
| 122 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.28002500 |
| 123 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.27551102 |
| 124 | Peyers patch development (GO:0048541) | 3.24391161 |
| 125 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.24391161 |
| 126 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.23823975 |
| 127 | dendritic cell chemotaxis (GO:0002407) | 3.23549650 |
| 128 | positive regulation of T cell activation (GO:0050870) | 3.22103582 |
| 129 | negative regulation of T cell mediated immunity (GO:0002710) | 3.20802254 |
| 130 | ribosomal small subunit assembly (GO:0000028) | 3.19861155 |
| 131 | positive regulation of interleukin-4 production (GO:0032753) | 3.19019856 |
| 132 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 3.18628738 |
| 133 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.18079213 |
| 134 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.18079213 |
| 135 | respiratory burst (GO:0045730) | 3.16330593 |
| 136 | regulation of interleukin-4 production (GO:0032673) | 3.16130367 |
| 137 | regulation of cell killing (GO:0031341) | 3.15273789 |
| 138 | regulation of monocyte chemotaxis (GO:0090025) | 3.14212163 |
| 139 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.12955400 |
| 140 | negative regulation of phagocytosis (GO:0050765) | 3.12452113 |
| 141 | positive regulation of T cell differentiation (GO:0045582) | 3.11953933 |
| 142 | negative regulation of B cell proliferation (GO:0030889) | 3.11032175 |
| 143 | heterotypic cell-cell adhesion (GO:0034113) | 3.10643697 |
| 144 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.10538909 |
| 145 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.10538909 |
| 146 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.10538909 |
| 147 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.09280227 |
| 148 | maturation of SSU-rRNA (GO:0030490) | 3.08943166 |
| 149 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.08608205 |
| 150 | response to interferon-beta (GO:0035456) | 3.07735888 |
| 151 | T cell differentiation involved in immune response (GO:0002292) | 3.07554628 |
| 152 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.07554628 |
| 153 | positive regulation of lamellipodium assembly (GO:0010592) | 3.06779448 |
| 154 | negative regulation of viral process (GO:0048525) | 3.03886023 |
| 155 | positive regulation of defense response to virus by host (GO:0002230) | 3.03015858 |
| 156 | negative regulation of actin filament bundle assembly (GO:0032232) | 3.00404350 |
| 157 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 11.2374595 |
| 158 | cytidine deamination (GO:0009972) | 11.0909692 |
| 159 | cytidine metabolic process (GO:0046087) | 11.0909692 |
| 160 | cytidine catabolic process (GO:0006216) | 11.0909692 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 8.30714466 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.16838136 |
| 3 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 5.24088651 |
| 4 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.97704395 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.82173672 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.76835026 |
| 7 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.76389817 |
| 8 | MYC_22102868_ChIP-Seq_BL_Human | 3.71687029 |
| 9 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.61348946 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.55383578 |
| 11 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.49555572 |
| 12 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.47711164 |
| 13 | MYB_26560356_Chip-Seq_TH2_Human | 3.10959278 |
| 14 | MAF_26560356_Chip-Seq_TH1_Human | 3.04533741 |
| 15 | UTX_26944678_Chip-Seq_JUKART_Human | 2.86750658 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.82844263 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.75513444 |
| 18 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.68808369 |
| 19 | MYB_26560356_Chip-Seq_TH1_Human | 2.66967288 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.52293188 |
| 21 | MAF_26560356_Chip-Seq_TH2_Human | 2.28405948 |
| 22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.24004780 |
| 23 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.13115468 |
| 24 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.08941221 |
| 25 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.08671863 |
| 26 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.06484565 |
| 27 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.05531969 |
| 28 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.04571496 |
| 29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.99696470 |
| 30 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.99673928 |
| 31 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.97144836 |
| 32 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.94142157 |
| 33 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91374066 |
| 34 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.89978372 |
| 35 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.79250416 |
| 36 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.78831433 |
| 37 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.76876133 |
| 38 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.71989832 |
| 39 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.71916270 |
| 40 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.67824683 |
| 41 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.65046667 |
| 42 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.64481504 |
| 43 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.62508969 |
| 44 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62358145 |
| 45 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.58162869 |
| 46 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57435823 |
| 47 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.56885927 |
| 48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.56214731 |
| 49 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.49580680 |
| 50 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44598658 |
| 51 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.41192177 |
| 52 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.38951706 |
| 53 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.38647839 |
| 54 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.36288552 |
| 55 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.34687708 |
| 56 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.34182161 |
| 57 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.33607363 |
| 58 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.33226525 |
| 59 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.29289230 |
| 60 | SPI1_23127762_ChIP-Seq_K562_Human | 1.28277977 |
| 61 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.27859864 |
| 62 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27652812 |
| 63 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.25783412 |
| 64 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.24632164 |
| 65 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22236630 |
| 66 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.22006347 |
| 67 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.20465093 |
| 68 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.20186441 |
| 69 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.18987935 |
| 70 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.15949039 |
| 71 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.15524879 |
| 72 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15172738 |
| 73 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.14909791 |
| 74 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.14816604 |
| 75 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.13652289 |
| 76 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.12779383 |
| 77 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.12225047 |
| 78 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.11435475 |
| 79 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.09871807 |
| 80 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.09779438 |
| 81 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.09224804 |
| 82 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08782836 |
| 83 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07999536 |
| 84 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.07757065 |
| 85 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07326425 |
| 86 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.07314625 |
| 87 | GATA3_26560356_Chip-Seq_TH2_Human | 1.05630123 |
| 88 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.04674774 |
| 89 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.98772892 |
| 90 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98118727 |
| 91 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98010412 |
| 92 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.97774794 |
| 93 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97247811 |
| 94 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.97051212 |
| 95 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97014889 |
| 96 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.96529151 |
| 97 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95024384 |
| 98 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.94929219 |
| 99 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.94681278 |
| 100 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.94444927 |
| 101 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94408092 |
| 102 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.93351736 |
| 103 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.92415408 |
| 104 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.92353892 |
| 105 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.91897830 |
| 106 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.91509537 |
| 107 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.91253248 |
| 108 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90817405 |
| 109 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.90591747 |
| 110 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.90088561 |
| 111 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.89265052 |
| 112 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.89092514 |
| 113 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.88908972 |
| 114 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.88599930 |
| 115 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.88418003 |
| 116 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.87924824 |
| 117 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.86183184 |
| 118 | AR_20517297_ChIP-Seq_VCAP_Human | 0.85507577 |
| 119 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.84652408 |
| 120 | SA1_27219007_Chip-Seq_Bcells_Human | 0.83547573 |
| 121 | NCOR_22424771_ChIP-Seq_293T_Human | 0.83136511 |
| 122 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81125785 |
| 123 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.81080361 |
| 124 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.81063509 |
| 125 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.80534566 |
| 126 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.79322294 |
| 127 | GATA3_26560356_Chip-Seq_TH1_Human | 0.78519254 |
| 128 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.78146554 |
| 129 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.78081363 |
| 130 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.77876527 |
| 131 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.77810829 |
| 132 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.77561619 |
| 133 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.77210901 |
| 134 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.74964980 |
| 135 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.74861862 |
| 136 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.74134566 |
| 137 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.73870004 |
| 138 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.73635860 |
| 139 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.73139200 |
| 140 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.72695389 |
| 141 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.71914539 |
| 142 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.70662485 |
| 143 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.69844180 |
| 144 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.68736714 |
| 145 | P300_27268052_Chip-Seq_Bcells_Human | 0.66899197 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 6.47425731 |
| 2 | MP0005671_abnormal_response_to | 4.35432348 |
| 3 | MP0000685_abnormal_immune_system | 4.27985193 |
| 4 | MP0001800_abnormal_humoral_immune | 3.23399186 |
| 5 | MP0005000_abnormal_immune_tolerance | 3.09598000 |
| 6 | MP0005387_immune_system_phenotype | 3.03691547 |
| 7 | MP0001790_abnormal_immune_system | 3.03691547 |
| 8 | MP0001835_abnormal_antigen_presentation | 3.02553608 |
| 9 | MP0002420_abnormal_adaptive_immunity | 2.99500707 |
| 10 | MP0002398_abnormal_bone_marrow | 2.96218474 |
| 11 | MP0002166_altered_tumor_susceptibility | 2.95827666 |
| 12 | MP0001819_abnormal_immune_cell | 2.95437834 |
| 13 | MP0002723_abnormal_immune_serum | 2.93828736 |
| 14 | MP0003436_decreased_susceptibility_to | 2.91366890 |
| 15 | MP0009785_altered_susceptibility_to | 2.90200251 |
| 16 | MP0000703_abnormal_thymus_morphology | 2.84364527 |
| 17 | MP0003724_increased_susceptibility_to | 2.83442644 |
| 18 | MP0009333_abnormal_splenocyte_physiolog | 2.80180740 |
| 19 | MP0002405_respiratory_system_inflammati | 2.76463576 |
| 20 | MP0002452_abnormal_antigen_presenting | 2.63924879 |
| 21 | MP0002933_joint_inflammation | 2.56835249 |
| 22 | MP0005025_abnormal_response_to | 2.55327083 |
| 23 | MP0000716_abnormal_immune_system | 2.53616355 |
| 24 | MP0002006_tumorigenesis | 2.44396796 |
| 25 | MP0003866_abnormal_defecation | 2.37988143 |
| 26 | MP0002722_abnormal_immune_system | 2.37725619 |
| 27 | MP0001873_stomach_inflammation | 2.30910796 |
| 28 | MP0000689_abnormal_spleen_morphology | 2.29429584 |
| 29 | MP0004510_myositis | 2.27697134 |
| 30 | MP0010155_abnormal_intestine_physiology | 2.16673585 |
| 31 | MP0004947_skin_inflammation | 2.16529470 |
| 32 | MP0006082_CNS_inflammation | 2.09154392 |
| 33 | MP0002429_abnormal_blood_cell | 2.02598601 |
| 34 | MP0010234_abnormal_vibrissa_follicle | 1.98126220 |
| 35 | MP0002396_abnormal_hematopoietic_system | 1.95073024 |
| 36 | MP0002148_abnormal_hypersensitivity_rea | 1.85510858 |
| 37 | MP0003300_gastrointestinal_ulcer | 1.83331742 |
| 38 | MP0005464_abnormal_platelet_physiology | 1.81996774 |
| 39 | MP0002419_abnormal_innate_immunity | 1.78315165 |
| 40 | MP0003303_peritoneal_inflammation | 1.65715471 |
| 41 | MP0001845_abnormal_inflammatory_respons | 1.62293751 |
| 42 | MP0004381_abnormal_hair_follicle | 1.58042714 |
| 43 | MP0005075_abnormal_melanosome_morpholog | 1.56764634 |
| 44 | MP0001853_heart_inflammation | 1.56734260 |
| 45 | MP0009379_abnormal_foot_pigmentation | 1.41555670 |
| 46 | MP0005166_decreased_susceptibility_to | 1.39615638 |
| 47 | MP0001542_abnormal_bone_strength | 1.37385167 |
| 48 | MP0000858_altered_metastatic_potential | 1.34635205 |
| 49 | MP0004808_abnormal_hematopoietic_stem | 1.28213255 |
| 50 | MP0002168_other_aberrant_phenotype | 1.27941780 |
| 51 | MP0005310_abnormal_salivary_gland | 1.21264312 |
| 52 | MP0005174_abnormal_tail_pigmentation | 1.20694963 |
| 53 | MP0001905_abnormal_dopamine_level | 1.19692477 |
| 54 | MP0001919_abnormal_reproductive_system | 1.19611239 |
| 55 | MP0004145_abnormal_muscle_electrophysio | 1.19066163 |
| 56 | MP0003786_premature_aging | 1.15642811 |
| 57 | MP0006054_spinal_hemorrhage | 1.11357176 |
| 58 | MP0001533_abnormal_skeleton_physiology | 1.11350561 |
| 59 | MP0002102_abnormal_ear_morphology | 1.10029989 |
| 60 | MP0000569_abnormal_digit_pigmentation | 1.09622083 |
| 61 | MP0002138_abnormal_hepatobiliary_system | 1.08773056 |
| 62 | MP0008469_abnormal_protein_level | 1.05250885 |
| 63 | MP0000604_amyloidosis | 1.04304515 |
| 64 | MP0005023_abnormal_wound_healing | 1.01971814 |
| 65 | MP0005645_abnormal_hypothalamus_physiol | 0.99692786 |
| 66 | MP0003172_abnormal_lysosome_physiology | 0.98031160 |
| 67 | MP0003137_abnormal_impulse_conducting | 0.97547131 |
| 68 | MP0000465_gastrointestinal_hemorrhage | 0.95093866 |
| 69 | MP0002277_abnormal_respiratory_mucosa | 0.93878279 |
| 70 | MP0008961_abnormal_basal_metabolism | 0.91815725 |
| 71 | MP0001851_eye_inflammation | 0.91550157 |
| 72 | MP0003453_abnormal_keratinocyte_physiol | 0.90793820 |
| 73 | MP0002019_abnormal_tumor_incidence | 0.89438251 |
| 74 | MP0003448_altered_tumor_morphology | 0.88887348 |
| 75 | MP0003806_abnormal_nucleotide_metabolis | 0.87600281 |
| 76 | MP0008873_increased_physiological_sensi | 0.86526591 |
| 77 | MP0000372_irregular_coat_pigmentation | 0.85249405 |
| 78 | MP0009765_abnormal_xenobiotic_induced | 0.85085241 |
| 79 | MP0003329_amyloid_beta_deposits | 0.83668808 |
| 80 | MP0002998_abnormal_bone_remodeling | 0.75747632 |
| 81 | MP0003075_altered_response_to | 0.74128678 |
| 82 | MP0001666_abnormal_nutrient_absorption | 0.73873870 |
| 83 | MP0001348_abnormal_lacrimal_gland | 0.72171045 |
| 84 | MP0002009_preneoplasia | 0.70242375 |
| 85 | MP0000015_abnormal_ear_pigmentation | 0.67916874 |
| 86 | MP0003878_abnormal_ear_physiology | 0.67118605 |
| 87 | MP0005377_hearing/vestibular/ear_phenot | 0.67118605 |
| 88 | MP0009763_increased_sensitivity_to | 0.66624365 |
| 89 | MP0004742_abnormal_vestibular_system | 0.66534599 |
| 90 | MP0002132_abnormal_respiratory_system | 0.65774797 |
| 91 | MP0001243_abnormal_dermal_layer | 0.65485150 |
| 92 | MP0004883_abnormal_blood_vessel | 0.64291474 |
| 93 | MP0005389_reproductive_system_phenotype | 0.63684064 |
| 94 | MP0009643_abnormal_urine_homeostasis | 0.62886452 |
| 95 | MP0005623_abnormal_meninges_morphology | 0.61175393 |
| 96 | MP0002877_abnormal_melanocyte_morpholog | 0.60653555 |
| 97 | MP0001661_extended_life_span | 0.59560919 |
| 98 | MP0000609_abnormal_liver_physiology | 0.59483424 |
| 99 | MP0005330_cardiomyopathy | 0.59019037 |
| 100 | MP0000490_abnormal_crypts_of | 0.57712807 |
| 101 | MP0003795_abnormal_bone_structure | 0.56907151 |
| 102 | MP0006036_abnormal_mitochondrial_physio | 0.55615259 |
| 103 | MP0008789_abnormal_olfactory_epithelium | 0.55440615 |
| 104 | MP0000383_abnormal_hair_follicle | 0.54730685 |
| 105 | MP0005636_abnormal_mineral_homeostasis | 0.54293102 |
| 106 | MP0001984_abnormal_olfaction | 0.53397842 |
| 107 | MP0003045_fibrosis | 0.53238284 |
| 108 | MP0005395_other_phenotype | 0.52648947 |
| 109 | MP0002163_abnormal_gland_morphology | 0.52497511 |
| 110 | MP0002095_abnormal_skin_pigmentation | 0.49953033 |
| 111 | MP0001765_abnormal_ion_homeostasis | 0.49761227 |
| 112 | MP0008872_abnormal_physiological_respon | 0.48589824 |
| 113 | MP0004130_abnormal_muscle_cell | 0.48183959 |
| 114 | MP0002136_abnormal_kidney_physiology | 0.47770963 |
| 115 | MP0003567_abnormal_fetal_cardiomyocyte | 0.47258186 |
| 116 | MP0001663_abnormal_digestive_system | 0.46354603 |
| 117 | MP0003195_calcinosis | 0.45107338 |
| 118 | MP0002089_abnormal_postnatal_growth/wei | 0.45095314 |
| 119 | MP0003077_abnormal_cell_cycle | 0.44972861 |
| 120 | MP0008057_abnormal_DNA_replication | 0.44568564 |
| 121 | MP0000371_diluted_coat_color | 0.43936470 |
| 122 | MP0001968_abnormal_touch/_nociception | 0.43195219 |
| 123 | MP0003690_abnormal_glial_cell | 0.43165687 |
| 124 | MP0009764_decreased_sensitivity_to | 0.42418588 |
| 125 | MP0003633_abnormal_nervous_system | 0.40555436 |
| 126 | MP0002822_catalepsy | 0.40544375 |
| 127 | MP0000920_abnormal_myelination | 0.40093411 |
| 128 | MP0002693_abnormal_pancreas_physiology | 0.39824908 |
| 129 | MP0001216_abnormal_epidermal_layer | 0.39539257 |
| 130 | MP0000343_altered_response_to | 0.39448219 |
| 131 | MP0000249_abnormal_blood_vessel | 0.38843241 |
| 132 | MP0000477_abnormal_intestine_morphology | 0.38366463 |
| 133 | MP0000367_abnormal_coat/_hair | 0.38109849 |
| 134 | MP0004957_abnormal_blastocyst_morpholog | 0.37271888 |
| 135 | MP0000313_abnormal_cell_death | 0.35058869 |
| 136 | MP0008569_lethality_at_weaning | 0.33587347 |
| 137 | MP0005397_hematopoietic_system_phenotyp | 0.32553531 |
| 138 | MP0001545_abnormal_hematopoietic_system | 0.32553531 |
| 139 | MP0002083_premature_death | 0.31800425 |
| 140 | MP0001191_abnormal_skin_condition | 0.30923932 |
| 141 | MP0000377_abnormal_hair_follicle | 0.30512325 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 7.91819310 |
| 2 | T lymphocytopenia (HP:0005403) | 7.29036923 |
| 3 | Aplastic anemia (HP:0001915) | 7.27131361 |
| 4 | Abnormality of T cell number (HP:0011839) | 7.00860276 |
| 5 | Severe combined immunodeficiency (HP:0004430) | 6.75771856 |
| 6 | Combined immunodeficiency (HP:0005387) | 6.22058146 |
| 7 | Increased IgM level (HP:0003496) | 5.81650580 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.71381003 |
| 9 | Abnormality of T cells (HP:0002843) | 5.67886885 |
| 10 | IgM deficiency (HP:0002850) | 5.60283503 |
| 11 | Eczematoid dermatitis (HP:0000976) | 5.52899551 |
| 12 | IgG deficiency (HP:0004315) | 5.51807600 |
| 13 | Hypoproteinemia (HP:0003075) | 5.48176389 |
| 14 | Panhypogammaglobulinemia (HP:0003139) | 5.17874144 |
| 15 | Recurrent bronchitis (HP:0002837) | 4.88545319 |
| 16 | Myositis (HP:0100614) | 4.81316216 |
| 17 | Recurrent fungal infections (HP:0002841) | 4.65339985 |
| 18 | Abnormality of T cell physiology (HP:0011840) | 4.20968056 |
| 19 | Abnormality of macrophages (HP:0004311) | 4.14106484 |
| 20 | Pustule (HP:0200039) | 4.01202254 |
| 21 | IgA deficiency (HP:0002720) | 3.91712448 |
| 22 | Retrobulbar optic neuritis (HP:0100654) | 3.89099558 |
| 23 | Optic neuritis (HP:0100653) | 3.89099558 |
| 24 | Joint swelling (HP:0001386) | 3.85988473 |
| 25 | Recurrent viral infections (HP:0004429) | 3.70929731 |
| 26 | Chronic diarrhea (HP:0002028) | 3.70439679 |
| 27 | Abnormality of the prostate (HP:0008775) | 3.67408397 |
| 28 | Recurrent cutaneous fungal infections (HP:0011370) | 3.66766274 |
| 29 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.66766274 |
| 30 | Nasal polyposis (HP:0100582) | 3.64493491 |
| 31 | Abnormality of eosinophils (HP:0001879) | 3.57234013 |
| 32 | B lymphocytopenia (HP:0010976) | 3.49897484 |
| 33 | Abnormality of B cell number (HP:0010975) | 3.49897484 |
| 34 | Hemiplegia (HP:0002301) | 3.39680618 |
| 35 | Eosinophilia (HP:0001880) | 3.37907255 |
| 36 | Lymphopenia (HP:0001888) | 3.35108395 |
| 37 | Autoimmune hemolytic anemia (HP:0001890) | 3.34414917 |
| 38 | Orchitis (HP:0100796) | 3.31781946 |
| 39 | Leukocytosis (HP:0001974) | 3.29415998 |
| 40 | Chronic otitis media (HP:0000389) | 3.22498650 |
| 41 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.21757388 |
| 42 | Recurrent sinusitis (HP:0011108) | 3.11891576 |
| 43 | Hypergammaglobulinemia (HP:0010702) | 3.10882935 |
| 44 | Abnormal albumin level (HP:0012116) | 3.05479794 |
| 45 | Hypoalbuminemia (HP:0003073) | 3.05479794 |
| 46 | 3-Methylglutaconic aciduria (HP:0003535) | 3.04562133 |
| 47 | Abnormality of the nasal mucosa (HP:0000433) | 3.03856808 |
| 48 | Thrombocytosis (HP:0001894) | 3.02145945 |
| 49 | Renal Fanconi syndrome (HP:0001994) | 3.01590691 |
| 50 | Increased intramyocellular lipid droplets (HP:0012240) | 2.96726336 |
| 51 | Generalized aminoaciduria (HP:0002909) | 2.94295438 |
| 52 | Granulocytopenia (HP:0001913) | 2.91758094 |
| 53 | Recurrent skin infections (HP:0001581) | 2.91037049 |
| 54 | Pancytopenia (HP:0001876) | 2.88510792 |
| 55 | Chest pain (HP:0100749) | 2.87286593 |
| 56 | Hemoptysis (HP:0002105) | 2.80730382 |
| 57 | Thyroiditis (HP:0100646) | 2.78931199 |
| 58 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.78236419 |
| 59 | Pulmonary infiltrates (HP:0002113) | 2.77079750 |
| 60 | Hypoplasia of the thymus (HP:0000778) | 2.76872170 |
| 61 | Meningitis (HP:0001287) | 2.75411707 |
| 62 | Vasculitis (HP:0002633) | 2.74889633 |
| 63 | Bronchitis (HP:0012387) | 2.71898136 |
| 64 | Mitochondrial inheritance (HP:0001427) | 2.67337578 |
| 65 | Keratoconjunctivitis sicca (HP:0001097) | 2.66311106 |
| 66 | Recurrent abscess formation (HP:0002722) | 2.60284540 |
| 67 | Lymphoma (HP:0002665) | 2.55593010 |
| 68 | Hepatocellular necrosis (HP:0001404) | 2.53466056 |
| 69 | Oral leukoplakia (HP:0002745) | 2.52686719 |
| 70 | Gingivitis (HP:0000230) | 2.51928130 |
| 71 | Gastrointestinal infarctions (HP:0005244) | 2.50319553 |
| 72 | Encephalitis (HP:0002383) | 2.45520900 |
| 73 | Mediastinal lymphadenopathy (HP:0100721) | 2.44323282 |
| 74 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.43965485 |
| 75 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.43965485 |
| 76 | Congenital stationary night blindness (HP:0007642) | 2.42705423 |
| 77 | Acute hepatic failure (HP:0006554) | 2.40168754 |
| 78 | Abnormality of the fingertips (HP:0001211) | 2.40062355 |
| 79 | Increased muscle lipid content (HP:0009058) | 2.39118935 |
| 80 | Keratoconjunctivitis (HP:0001096) | 2.38397399 |
| 81 | Reticulocytopenia (HP:0001896) | 2.33843205 |
| 82 | Recurrent otitis media (HP:0000403) | 2.33493377 |
| 83 | Abnormality of the pleura (HP:0002103) | 2.29783844 |
| 84 | Inflammation of the large intestine (HP:0002037) | 2.29474247 |
| 85 | Amyotrophic lateral sclerosis (HP:0007354) | 2.25270509 |
| 86 | Severe visual impairment (HP:0001141) | 2.24060168 |
| 87 | Autoimmune thrombocytopenia (HP:0001973) | 2.23047083 |
| 88 | Arterial thrombosis (HP:0004420) | 2.22019421 |
| 89 | Hyponatremia (HP:0002902) | 2.21638625 |
| 90 | 11 pairs of ribs (HP:0000878) | 2.20646061 |
| 91 | Basal cell carcinoma (HP:0002671) | 2.19062137 |
| 92 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.18068175 |
| 93 | Gastrointestinal inflammation (HP:0004386) | 2.17245459 |
| 94 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.16267813 |
| 95 | Pulmonary embolism (HP:0002204) | 2.14140615 |
| 96 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.13375761 |
| 97 | Hepatic necrosis (HP:0002605) | 2.11145982 |
| 98 | Abnormality of male internal genitalia (HP:0000022) | 2.10690327 |
| 99 | Renal cortical cysts (HP:0000803) | 2.09383520 |
| 100 | Increased hepatocellular lipid droplets (HP:0006565) | 2.08178638 |
| 101 | Hepatitis (HP:0012115) | 2.06966243 |
| 102 | Obstructive lung disease (HP:0006536) | 2.06797306 |
| 103 | Chronic obstructive pulmonary disease (HP:0006510) | 2.06797306 |
| 104 | Increased density of long bones (HP:0006392) | 2.01801165 |
| 105 | Acute necrotizing encephalopathy (HP:0006965) | 1.99696983 |
| 106 | Gastrointestinal stroma tumor (HP:0100723) | 1.99022699 |
| 107 | Increased IgE level (HP:0003212) | 1.96869066 |
| 108 | Increased CSF lactate (HP:0002490) | 1.96492806 |
| 109 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.94956602 |
| 110 | Skin rash (HP:0000988) | 1.93336958 |
| 111 | Large eyes (HP:0001090) | 1.93316027 |
| 112 | Agammaglobulinemia (HP:0004432) | 1.92784032 |
| 113 | Multiple enchondromatosis (HP:0005701) | 1.90582618 |
| 114 | Epistaxis (HP:0000421) | 1.90250761 |
| 115 | Ureteral stenosis (HP:0000071) | 1.88180342 |
| 116 | Increased serum ferritin (HP:0003281) | 1.87942473 |
| 117 | Arthralgia (HP:0002829) | 1.87585271 |
| 118 | Cheilitis (HP:0100825) | 1.87404599 |
| 119 | Gingival bleeding (HP:0000225) | 1.87135726 |
| 120 | Cellular immunodeficiency (HP:0005374) | 1.85456026 |
| 121 | Spontaneous hematomas (HP:0007420) | 1.85136191 |
| 122 | Abnormality of the endocardium (HP:0004306) | 1.84607012 |
| 123 | Skin ulcer (HP:0200042) | 1.82360099 |
| 124 | Gangrene (HP:0100758) | 1.82294934 |
| 125 | Petechiae (HP:0000967) | 1.82130356 |
| 126 | Abnormality of the pericardium (HP:0001697) | 1.78582835 |
| 127 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.77742677 |
| 128 | Emphysema (HP:0002097) | 1.77579156 |
| 129 | Papilloma (HP:0012740) | 1.76918712 |
| 130 | Verrucae (HP:0200043) | 1.76918712 |
| 131 | Ragged-red muscle fibers (HP:0003200) | 1.76548507 |
| 132 | Pigmentary retinal degeneration (HP:0001146) | 1.75040169 |
| 133 | Prolonged bleeding time (HP:0003010) | 1.74435480 |
| 134 | Pulmonary fibrosis (HP:0002206) | 1.73194492 |
| 135 | Anorexia (HP:0002039) | 1.72318949 |
| 136 | Distal arthrogryposis (HP:0005684) | 1.71654450 |
| 137 | Recurrent bacterial skin infections (HP:0005406) | 1.69915389 |
| 138 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.66729016 |
| 139 | Ureteral obstruction (HP:0006000) | 1.64799208 |
| 140 | Bronchiectasis (HP:0002110) | 1.64653029 |
| 141 | Restrictive lung disease (HP:0002091) | 1.64645736 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 6.59933172 |
| 2 | MAP4K1 | 6.53425345 |
| 3 | ZAP70 | 4.58053462 |
| 4 | MAP3K12 | 3.92584154 |
| 5 | TESK2 | 3.79377628 |
| 6 | ITK | 2.80211208 |
| 7 | BCKDK | 2.78693993 |
| 8 | KDR | 2.46468463 |
| 9 | JAK3 | 2.44013948 |
| 10 | FGFR4 | 2.40358861 |
| 11 | SRPK1 | 2.30242255 |
| 12 | IKBKE | 1.98779275 |
| 13 | LCK | 1.95075523 |
| 14 | TAOK3 | 1.91675025 |
| 15 | TYK2 | 1.88959239 |
| 16 | STK10 | 1.79368496 |
| 17 | TESK1 | 1.79030630 |
| 18 | SIK3 | 1.66871031 |
| 19 | NLK | 1.64861728 |
| 20 | TEC | 1.56748640 |
| 21 | GRK6 | 1.50867406 |
| 22 | SYK | 1.45771406 |
| 23 | MYLK | 1.45761639 |
| 24 | CSK | 1.42895973 |
| 25 | MAP3K14 | 1.42289428 |
| 26 | VRK1 | 1.38590869 |
| 27 | BUB1 | 1.37760511 |
| 28 | MAP3K11 | 1.37186506 |
| 29 | MAPKAPK3 | 1.35957884 |
| 30 | VRK2 | 1.34875427 |
| 31 | JAK1 | 1.27553156 |
| 32 | SIK2 | 1.19727233 |
| 33 | FGFR3 | 1.17996333 |
| 34 | HCK | 1.17708837 |
| 35 | ADRBK2 | 1.17687583 |
| 36 | ZAK | 1.16644427 |
| 37 | CAMKK2 | 1.16036302 |
| 38 | GRK7 | 1.13990402 |
| 39 | LIMK1 | 1.12321094 |
| 40 | BTK | 1.11148253 |
| 41 | NME2 | 1.09413502 |
| 42 | PRKCQ | 1.05995598 |
| 43 | TBK1 | 0.98795306 |
| 44 | FGFR1 | 0.96727302 |
| 45 | MAP2K6 | 0.93009009 |
| 46 | EEF2K | 0.88920949 |
| 47 | PKN2 | 0.87237563 |
| 48 | MARK3 | 0.86366886 |
| 49 | GRK1 | 0.86175953 |
| 50 | SIK1 | 0.86120329 |
| 51 | PRKCH | 0.85999195 |
| 52 | MAP3K13 | 0.84995728 |
| 53 | DAPK1 | 0.84968458 |
| 54 | IKBKB | 0.82670073 |
| 55 | MAP3K10 | 0.80055580 |
| 56 | LRRK2 | 0.79485838 |
| 57 | LYN | 0.77689067 |
| 58 | MST4 | 0.76764497 |
| 59 | PDGFRB | 0.75217245 |
| 60 | BLK | 0.71035862 |
| 61 | RPS6KA4 | 0.69941733 |
| 62 | CHUK | 0.67945245 |
| 63 | DAPK2 | 0.66340383 |
| 64 | MARK2 | 0.66128857 |
| 65 | NME1 | 0.65162400 |
| 66 | ROCK1 | 0.63355478 |
| 67 | MAP3K7 | 0.61964193 |
| 68 | STK24 | 0.60241792 |
| 69 | JAK2 | 0.60020078 |
| 70 | CAMKK1 | 0.59981286 |
| 71 | FYN | 0.59206872 |
| 72 | EIF2AK1 | 0.57706100 |
| 73 | KIT | 0.55885125 |
| 74 | ILK | 0.54787473 |
| 75 | AURKA | 0.53792233 |
| 76 | SCYL2 | 0.50997489 |
| 77 | TAOK1 | 0.50895090 |
| 78 | RIPK4 | 0.50165223 |
| 79 | PASK | 0.49661086 |
| 80 | INSR | 0.49218300 |
| 81 | PINK1 | 0.48984912 |
| 82 | MAP2K3 | 0.48858719 |
| 83 | TIE1 | 0.47965595 |
| 84 | TRPM7 | 0.47289874 |
| 85 | MAP4K2 | 0.46970570 |
| 86 | ROCK2 | 0.46676588 |
| 87 | TLK1 | 0.46523828 |
| 88 | CLK1 | 0.45230942 |
| 89 | PIM1 | 0.43647677 |
| 90 | CDK19 | 0.43158654 |
| 91 | DAPK3 | 0.42449514 |
| 92 | TSSK6 | 0.41969347 |
| 93 | PAK4 | 0.40858604 |
| 94 | IRAK4 | 0.40414250 |
| 95 | TRIB3 | 0.40313018 |
| 96 | FRK | 0.39987770 |
| 97 | WNK4 | 0.39835186 |
| 98 | FES | 0.39157138 |
| 99 | STK16 | 0.38595775 |
| 100 | OBSCN | 0.37310629 |
| 101 | PIK3CG | 0.36187437 |
| 102 | MAP3K1 | 0.35904737 |
| 103 | EIF2AK3 | 0.35363990 |
| 104 | INSRR | 0.34754455 |
| 105 | TYRO3 | 0.34249193 |
| 106 | PAK1 | 0.33625249 |
| 107 | IGF1R | 0.33103794 |
| 108 | PRKCA | 0.32510972 |
| 109 | TNK2 | 0.32323221 |
| 110 | EPHA3 | 0.31776597 |
| 111 | PIM2 | 0.29052932 |
| 112 | MAP2K7 | 0.28611736 |
| 113 | MATK | 0.27548678 |
| 114 | MAPK11 | 0.26867832 |
| 115 | TGFBR2 | 0.25495543 |
| 116 | RPS6KA5 | 0.25152757 |
| 117 | CAMK2A | 0.24773999 |
| 118 | OXSR1 | 0.24206911 |
| 119 | MAPKAPK2 | 0.24162413 |
| 120 | CSNK1A1 | 0.23871090 |
| 121 | TTN | 0.23657412 |
| 122 | EPHB1 | 0.23168802 |
| 123 | PTK2 | 0.22840651 |
| 124 | ATR | 0.22797475 |
| 125 | ERBB3 | 0.21782456 |
| 126 | ALK | 0.21606377 |
| 127 | NEK6 | 0.21559279 |
| 128 | SRC | 0.21405223 |
| 129 | HIPK2 | 0.21014318 |
| 130 | CDK12 | 0.20759661 |
| 131 | MAPK13 | 0.20234164 |
| 132 | PRKCB | 0.20108390 |
| 133 | MUSK | 0.20020895 |
| 134 | RAF1 | 0.19855854 |
| 135 | PDK1 | 0.19286140 |
| 136 | PRKACA | 0.19278545 |
| 137 | PRKCD | 0.19267465 |
| 138 | CSF1R | 0.19159868 |
| 139 | MAP3K8 | 0.18953621 |
| 140 | MAPK3 | 0.18928153 |
| 141 | MAP3K5 | 0.18743730 |
| 142 | CSNK1G3 | 0.18665247 |
| 143 | EGFR | 0.18258333 |
| 144 | ABL1 | 0.16376960 |
| 145 | DMPK | 0.15819538 |
| 146 | NTRK2 | 0.15603410 |
| 147 | TGFBR1 | 0.13961311 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.57787248 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 4.44059928 |
| 3 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.69391512 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.52959059 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 3.09258365 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.08711162 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.07084304 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.00270503 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.74898571 |
| 10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.74391205 |
| 11 | Measles_Homo sapiens_hsa05162 | 2.57958183 |
| 12 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.42229906 |
| 13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.32438267 |
| 14 | Parkinsons disease_Homo sapiens_hsa05012 | 2.15622953 |
| 15 | Viral myocarditis_Homo sapiens_hsa05416 | 2.03870065 |
| 16 | Ribosome_Homo sapiens_hsa03010 | 2.00742434 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.75124871 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.65392484 |
| 19 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.64580527 |
| 20 | Leishmaniasis_Homo sapiens_hsa05140 | 1.59933204 |
| 21 | Asthma_Homo sapiens_hsa05310 | 1.59688453 |
| 22 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.50076146 |
| 23 | Alzheimers disease_Homo sapiens_hsa05010 | 1.46429945 |
| 24 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.32625133 |
| 25 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.31723895 |
| 26 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.31652008 |
| 27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.29152699 |
| 28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.28836803 |
| 29 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.27103850 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.24208721 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.24052648 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.22838085 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.22746285 |
| 34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.20314446 |
| 35 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.18513914 |
| 36 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.14555443 |
| 37 | Hepatitis B_Homo sapiens_hsa05161 | 1.10505567 |
| 38 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.08911974 |
| 39 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.08311385 |
| 40 | Huntingtons disease_Homo sapiens_hsa05016 | 1.07163379 |
| 41 | Shigellosis_Homo sapiens_hsa05131 | 1.01372598 |
| 42 | HTLV-I infection_Homo sapiens_hsa05166 | 1.00533013 |
| 43 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.94163600 |
| 44 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.93048498 |
| 45 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.92877067 |
| 46 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.90022770 |
| 47 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.89200729 |
| 48 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.88734458 |
| 49 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.87529582 |
| 50 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.81147399 |
| 51 | Spliceosome_Homo sapiens_hsa03040 | 0.79091047 |
| 52 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.79071418 |
| 53 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.78374061 |
| 54 | Malaria_Homo sapiens_hsa05144 | 0.76577331 |
| 55 | Platelet activation_Homo sapiens_hsa04611 | 0.76530767 |
| 56 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.74669546 |
| 57 | Apoptosis_Homo sapiens_hsa04210 | 0.73183539 |
| 58 | Legionellosis_Homo sapiens_hsa05134 | 0.72004714 |
| 59 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.70124729 |
| 60 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.69342423 |
| 61 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.66537433 |
| 62 | Influenza A_Homo sapiens_hsa05164 | 0.66469506 |
| 63 | Phototransduction_Homo sapiens_hsa04744 | 0.66267243 |
| 64 | RNA degradation_Homo sapiens_hsa03018 | 0.65835922 |
| 65 | Colorectal cancer_Homo sapiens_hsa05210 | 0.63811343 |
| 66 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.62261065 |
| 67 | Hepatitis C_Homo sapiens_hsa05160 | 0.60130972 |
| 68 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.60106571 |
| 69 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.57152161 |
| 70 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.55522535 |
| 71 | Thyroid cancer_Homo sapiens_hsa05216 | 0.55488767 |
| 72 | Endocytosis_Homo sapiens_hsa04144 | 0.54109040 |
| 73 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.51465277 |
| 74 | Peroxisome_Homo sapiens_hsa04146 | 0.51356931 |
| 75 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.50373258 |
| 76 | Salmonella infection_Homo sapiens_hsa05132 | 0.50357812 |
| 77 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.48872101 |
| 78 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.48280829 |
| 79 | Pertussis_Homo sapiens_hsa05133 | 0.47324716 |
| 80 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.43816907 |
| 81 | Tuberculosis_Homo sapiens_hsa05152 | 0.43442749 |
| 82 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.41932926 |
| 83 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.40787272 |
| 84 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.40740585 |
| 85 | Prion diseases_Homo sapiens_hsa05020 | 0.40572574 |
| 86 | Insulin resistance_Homo sapiens_hsa04931 | 0.39753370 |
| 87 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.38603280 |
| 88 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.37597265 |
| 89 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.36811734 |
| 90 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.34789240 |
| 91 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.34667658 |
| 92 | Proteasome_Homo sapiens_hsa03050 | 0.30340275 |
| 93 | RNA polymerase_Homo sapiens_hsa03020 | 0.30279196 |
| 94 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.29692293 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.29318101 |
| 96 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.28658986 |
| 97 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.28569929 |
| 98 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.28510825 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.28460659 |
| 100 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.26337434 |
| 101 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.26132442 |
| 102 | Taste transduction_Homo sapiens_hsa04742 | 0.25658447 |
| 103 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.25489064 |
| 104 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.24979266 |
| 105 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.24360722 |
| 106 | RNA transport_Homo sapiens_hsa03013 | 0.23320653 |
| 107 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.23099559 |
| 108 | Retinol metabolism_Homo sapiens_hsa00830 | 0.22953980 |
| 109 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.20955067 |
| 110 | Protein export_Homo sapiens_hsa03060 | 0.20188510 |
| 111 | Phagosome_Homo sapiens_hsa04145 | 0.19804164 |
| 112 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.19290887 |
| 113 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.18967180 |
| 114 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.18030925 |
| 115 | Olfactory transduction_Homo sapiens_hsa04740 | 0.17623626 |
| 116 | DNA replication_Homo sapiens_hsa03030 | 0.16366961 |
| 117 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.15998330 |
| 118 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.15465083 |
| 119 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.15372620 |
| 120 | Circadian rhythm_Homo sapiens_hsa04710 | 0.15175787 |
| 121 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.14267333 |
| 122 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.13936722 |
| 123 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.13593575 |
| 124 | Homologous recombination_Homo sapiens_hsa03440 | 0.13438893 |
| 125 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.12759366 |
| 126 | Pathways in cancer_Homo sapiens_hsa05200 | 0.11598984 |
| 127 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.11016111 |
| 128 | Alcoholism_Homo sapiens_hsa05034 | 0.10583555 |
| 129 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.09595205 |
| 130 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.08632735 |
| 131 | Prostate cancer_Homo sapiens_hsa05215 | 0.08253860 |
| 132 | Purine metabolism_Homo sapiens_hsa00230 | 0.08148611 |
| 133 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.08044803 |
| 134 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.07021076 |
| 135 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.06711809 |
| 136 | Lysosome_Homo sapiens_hsa04142 | 0.05539389 |
| 137 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.05186073 |
| 138 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.04023289 |
| 139 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.02715853 |
| 140 | Focal adhesion_Homo sapiens_hsa04510 | 0.02579665 |

